Semantic Scholar uses AI to extract papers important to this topic.
Hormonal therapy is the main recommended treatment for locally advanced and metastatic prostate cancer. Luteinizing hormone… Expand Abarelix, a gonadotropin-releasing hormone antagonist, with its indication for advanced symptomatic prostate cancer, represents… Expand The high incidence of prostate cancer makes it a major healthcare problem and the second leading cancer-related cause of death… Expand OBJECTIVES
To evaluate the ability of abarelix, a gonadotropin-releasing hormone antagonist, to provide an alternative treatment… Expand PURPOSE
We compared the endocrinological and biochemical efficacy of abarelix depot, a gonadotropin-releasing hormone antagonist… Expand We describe the pharmacological profile in rats and monkeys of degarelix (FE200486), a member of a new class of long-acting… Expand OBJECTIVES
To evaluate the levels of testosterone and other hormones in men with prostate cancer treated with abarelix versus… Expand PURPOSE
We contrasted the endocrinological and biochemical efficacies of abarelix depot, a pure gonadotropin-releasing hormone… Expand A series of antagonists of gonadotropin-releasing hormone (GnRH) of the general formula Ac-D2Nal-D4Cpa-D3Pal-Ser-4Aph/4Amf(P… Expand PURPOSE
A Phase II clinical study contrasted the endocrinologic and biochemical efficacy of Abarelix Depot, a gonadotropin… Expand